• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠十二指肠内注射尿激酶后的血浆纤维蛋白溶解作用。

Plasma fibrinolysis after intraduodenal administration of urokinase in rats.

作者信息

Sumi H, Seiki M, Morimoto N, Tsushima H, Maruyama M, Mihara H

出版信息

Enzyme. 1985;33(3):122-7.

PMID:4054071
Abstract

Plasma fibrinolysis in rats rose above the level of physiological fluctuations in a curve with two peaks at 1 and 6 h, following intraduodenal administration of high-molecular-weight urokinase (HMW-UK; MW 53,000; 124,000 IU/mg protein). Activation of plasma fibrinolysis was also confirmed with insolubilized enzyme (glass-coupled UK), but lacked the first activity peak. Plasma fibrinolytic enzyme isolated by affinity chromatography revealed strong fibrinolytic (1,120 IU/dl), pyro-Glu-Gly-Arg-pNA amidolytic (3,200 nmol/dl) and Glu-plasminogen activating (24.5 IU/dl) activities. Using specific UK antibody, it appeared that the first peak originated from the administered UK, while the second one derived from endogenous plasminogen activator. Dose response of UK was not observed, and the maximal effect was at about 5,000 IU/kg body weight.

摘要

十二指肠内给予高分子量尿激酶(HMW-UK;分子量53,000;124,000 IU/mg蛋白)后,大鼠血浆纤维蛋白溶解呈曲线上升,超过生理波动水平,在1小时和6小时出现两个峰值。用固定化酶(玻璃偶联尿激酶)也证实了血浆纤维蛋白溶解的激活,但没有第一个活性峰值。通过亲和层析分离的血浆纤维蛋白溶解酶显示出很强的纤维蛋白溶解活性(1,120 IU/dl)、焦谷氨酸-甘氨酸-精氨酸-对硝基苯胺酰胺水解活性(3,200 nmol/dl)和谷氨酸纤溶酶原激活活性(24.5 IU/dl)。使用特异性尿激酶抗体,似乎第一个峰值源于所给予的尿激酶,而第二个峰值来自内源性纤溶酶原激活剂。未观察到尿激酶的剂量反应,最大效应出现在约5,000 IU/kg体重时。

相似文献

1
Plasma fibrinolysis after intraduodenal administration of urokinase in rats.大鼠十二指肠内注射尿激酶后的血浆纤维蛋白溶解作用。
Enzyme. 1985;33(3):122-7.
2
Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
Alcohol Alcohol. 1988;23(1):33-43.
3
Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.在刺激尿激酶型蛋白合成和/或释放的情况下,尿激酶在正常人类受试者肠道中的转运。
J Clin Invest. 1985 Apr;75(4):1212-22. doi: 10.1172/JCI111818.
4
Activation of plasma fibrinolysis after intrarectal administration of high molecular weight urokinase and its derivative.直肠内给予高分子量尿激酶及其衍生物后血浆纤维蛋白溶解的激活。
Acta Haematol. 1983;70(5):289-95. doi: 10.1159/000206755.
5
Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):122-36.
6
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
7
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.人尿激酶原酶及活性形式的生物学和溶栓特性——IV. 几种哺乳动物血浆纤溶反应的变异性
Thromb Haemost. 1984 Aug 31;52(1):31-3.
8
Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.纤维蛋白存在下高分子量和低分子量尿激酶活性的比较研究
Thromb Haemost. 1982 Feb 26;47(1):36-40.
9
The biphasic nature and temperature dependence of the activation of human plasminogen by urokinase. A simple urokinase assay based on this phenomenon.
Res Commun Chem Pathol Pharmacol. 1979 May;24(2):339-47.
10
[Role of single chain pro-UK on the initiation and regulation of fibrinolysis].[单链前尿激酶在纤溶启动及调控中的作用]
Rinsho Byori. 1989 Apr;Spec No 81:107-17.

引用本文的文献

1
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor.外源性尿激酶抑制其同源尿激酶型纤溶酶原激活物受体的蛋白酶体降解。
Front Pharmacol. 2022 Aug 12;13:754271. doi: 10.3389/fphar.2022.754271. eCollection 2022.
2
Connective tissue: Vascular and hematological (blood) support.结缔组织:血管和血液(造血)支持。
J Chiropr Med. 2003 Winter;2(1):25-36. doi: 10.1016/S0899-3467(07)60070-6.